Latest news
Innate Pharma price target raised to $7 from $5 at H.C. Wainwright - TipRanksTipRanks · Mon, 10 Aug 2026 16:32:50 GMTSobi, Innate sign $580M pact to propel lymphoma drug through Phase III - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 15:22:30 GMTSwedish kiss for french Innate: Sobi backs Innate’s lacutamab as rare T-cell lymphoma program enters Phase 3 - European Biotechnology MagazineEuropean Biotechnology Magazine · Mon, 10 Aug 2026 14:03:25 GMTM&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo - Pharmaceutical ExecutivePharmaceutical Executive · Mon, 10 Aug 2026 13:53:58 GMTSobi broadens portfolio through partnership with Innate Pharma - BiostockBiostock · Mon, 10 Aug 2026 12:21:58 GMTInnate Pharma S.A. and Swedish Orphan Biovitrum AB Enter Licensing Agreement for Lacutamab in T-Cell Lymphoma - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 11:52:53 GMTNews round-up Monday, August 10 - BiostockBiostock · Mon, 10 Aug 2026 10:29:39 GMTInnate Pharma (NASDAQ: IPHA) secures Sobi deal, $75M upfront and Phase 3 push - Stock TitanStock Titan · Mon, 10 Aug 2026 10:05:10 GMT